Literature DB >> 17873826

Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.

Bo-Sung Kang1, Moon Suk Bang, Se Hee Jung.   

Abstract

OBJECTIVE: To assess the additive effect of adjuvant electrical stimulation on botulinum toxin A injection in children with spastic diplegic cerebral palsy.
DESIGN: Eighteen children with dynamic foot equinus deformity were treated with botulinum toxin A injection into the calf muscles. Seven children were assigned to a treatment group who received botulinum toxin A and adjuvant electrical stimulation, and 11 children were assigned to a control group with botulinum toxin injection only. Before botulinum injection, and at 2 wks and 3 mos after injection, the Physician Rating Scale, passive ranges of ankle and knee motion, and the modified Ashworth scale were measured.
RESULTS: A significant increase in passive range of ankle motion was observed at 2 wks after injection in the treatment group and at 3 mos after injection in both groups. Both groups showed significant improvements by the modified Ashworth scale at 2 wks after injection. Subscales of the Physician Rating Scale (equinus foot, crouched gait) and total Physician Rating Scale scores were significantly improved in the treatment group at 3 mos after injection, but this was not observed in the control group.
CONCLUSIONS: Adjuvant electrical stimulation for a short period after botulinum toxin A injection was found to benefit early improvement of range of motion and maintenance of gait improvement in children with spastic diplegia cerebral palsy showing dynamic equinus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873826     DOI: 10.1097/PHM.0b013e3181520449

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

Review 1.  Neuromuscular electrical stimulation to improve gross motor function in children with cerebral palsy: a meta-analysis.

Authors:  Ana Paula Salazar; Aline Souza Pagnussat; Gabriela Alves Pereira; Gabriela Scopel; Janice Luisa Lukrafka
Journal:  Braz J Phys Ther       Date:  2019-01-23       Impact factor: 3.377

Review 2.  Relationship between ankle function and walking ability for children and young adults with cerebral palsy: A systematic review of deficits and targeted interventions.

Authors:  Benjamin C Conner; Nushka M Remec; Cassidy M Michaels; Chase W Wallace; Emily Andrisevic; Zachary F Lerner
Journal:  Gait Posture       Date:  2021-10-25       Impact factor: 2.840

3.  Effectiveness of electrical stimulation after administration of botulinum toxin in children with spastic diplegic cerebral palsy: A prospective, randomized clinical study.

Authors:  Pembe Yiğitoğlu; Erkan Kozanoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-02-04

Review 4.  Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.

Authors:  Francesco C Blumetti; João Carlos Belloti; Marcel Js Tamaoki; José A Pinto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-08

Review 5.  Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art.

Authors:  Alessandro Picelli; Mirko Filippetti; Giorgio Sandrini; Cristina Tassorelli; Roberto De Icco; Nicola Smania; Stefano Tamburin
Journal:  Toxins (Basel)       Date:  2021-04-23       Impact factor: 4.546

6.  High-frequency, low-magnitude vibration does not prevent bone loss resulting from muscle disuse in mice following botulinum toxin injection.

Authors:  Sarah L Manske; Craig A Good; Ronald F Zernicke; Steven K Boyd
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

7.  Toward a hybrid exoskeleton for crouch gait in children with cerebral palsy: neuromuscular electrical stimulation for improved knee extension.

Authors:  Blynn L Shideler; Thomas C Bulea; Ji Chen; Christopher J Stanley; Andrew J Gravunder; Diane L Damiano
Journal:  J Neuroeng Rehabil       Date:  2020-09-03       Impact factor: 4.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.